The safety and contraceptive efficacy of a 24-day low-dose oral contraceptive regimen containing gestodene 60 µg and ethinylestradiol 15 µg
Gestodene Study Group 322 - The European Journal of …, 1999 - Taylor & Francis
Objectives: The safety and contraceptive efficacy of a new 24-day regimen of an oral
contraceptive combination containing gestodene (GTD) 60 µg and ethinylestradiol (EE) 15 …
contraceptive combination containing gestodene (GTD) 60 µg and ethinylestradiol (EE) 15 …
Multicenter study of the efficacy, cycle control and tolerability of a phasic desogestrel-containing oral contraceptive
H Ferguson, ML Vree, J Wilpshaar… - The European Journal of …, 2000 - Taylor & Francis
Objective To investigate the efficacy, cycle control and tolerability of a phasic oral
contraceptive containing ethinylestradiol 35/30/30 μg and desogestrel 50/100/150 μg …
contraceptive containing ethinylestradiol 35/30/30 μg and desogestrel 50/100/150 μg …
Latin American experience with two low–dose oral contraceptives containing 30 μg ethinylestradiol/75 μg gestodene and 20 μg ethinylestradiol/150 μg desogestrel
S Bassol, A Alvarado, C Celis, MC Cravioto, O Peralta… - Contraception, 2000 - Elsevier
The objective of this study was to compare cycle control, efficacy and tolerance of an oral
contraceptive containing 20 μg ethinylestradiol and 150 μg desogestrel with a preparation …
contraceptive containing 20 μg ethinylestradiol and 150 μg desogestrel with a preparation …
A comparison of cycle control and effect on well-being of monophasic gestodene-, triphasic gestodene-and monophasic desogestrel-containing oral contraceptives
V Bruni, H Croxatto, J De La Cruz, M Dhont… - Gynecological …, 2000 - Taylor & Francis
This was an open-label multicenter study to compare the cycle control and effect on well-
being of two oral contraceptives containing gestodene and one containing desogestrel. A …
being of two oral contraceptives containing gestodene and one containing desogestrel. A …
Effect of a low-dose contraceptive patch on efficacy, bleeding pattern, and safety: a 1-year, multicenter, open-label, uncontrolled study
I Wiegratz, S Bassol, E Weisberg… - Reproductive …, 2014 - journals.sagepub.com
This Phase III, uncontrolled, open-label, multicenter study was conducted to investigate the
contraceptive efficacy, bleeding pattern, and cycle control of a novel once-a-week …
contraceptive efficacy, bleeding pattern, and cycle control of a novel once-a-week …
Multicenter, comparative study of cycle control, efficacy and tolerability of two low-dose oral contraceptives containing 20 μg ethinylestradiol/100 μg levonorgestrel and …
J Endrikat, R Hite, R Bannemerschult, C Gerlinger… - Contraception, 2001 - Elsevier
A comparison of cycle control, efficacy and tolerability of two oral contraceptive preparations
containing 20 μg ethinylestradiol combined with either 100 μg levonorgestrel (EE/LNG …
containing 20 μg ethinylestradiol combined with either 100 μg levonorgestrel (EE/LNG …
Clinical experience with a low-dose oral contraceptive containing gestodene.
B Düsterberg, K Brill - … in Contraception: the Official Journal of the …, 1990 - europepmc.org
The monophasic combination preparation containing 30 micrograms ethinyl estradiol and
75 micrograms gestodene was tested for contraceptive reliability, cycle control and …
75 micrograms gestodene was tested for contraceptive reliability, cycle control and …
Effects of two combined oral contraceptives containing ethinyl estradiol 30 μg combined with either gestodene or drospirenone on hemostatic parameters, lipid profiles …
R Yildizhan, B Yildizhan, E Adali, P Yoruk… - Archives of gynecology …, 2009 - Springer
Objective The aim of this study is to compare the effect of ethinyl estradiol 0.03
mg/gestodene 0.075 mg (EE/GSD) with ethinylestradiol 0.03 mg/drospirenone 3 mg …
mg/gestodene 0.075 mg (EE/GSD) with ethinylestradiol 0.03 mg/drospirenone 3 mg …
Adding low-dose estrogen to the hormone-free interval: impact on bleeding patterns in users of a 91-day extended regimen oral contraceptive
AM Kaunitz, DJ Portman, H Hait, KZ Reape - Contraception, 2009 - Elsevier
BACKGROUND: A cross-study analysis of contraceptive clinical trials for two different 91-day
oral contraceptive (OC) regimens was performed to examine the impact on bleeding …
oral contraceptive (OC) regimens was performed to examine the impact on bleeding …
Efficacy and acceptability of two monophasic oral contraceptives containing ethinylestradiol and either desogestrel or gestodene
HW Halbe, NR De Melo, L Bahamondes… - … European Journal of …, 1998 - Taylor & Francis
Objective To assess the contraceptive efficacy, cycle control and acceptability of two
monophasic oral contraceptives containing either 30 µg ethinylestradiol plus 150 µg …
monophasic oral contraceptives containing either 30 µg ethinylestradiol plus 150 µg …